Consortium Consortium
 EuroDSD - members of the EuroDSD consortium

QuicklinksQuicklinks
Project objectives Project objectives Project impact Project impact Coordinator / Project Office Coordinator / Project Office Upcoming meetings Upcoming meetings Publications Publications




SEVENTH FRAMEWORK PROGRAMME

Universitätsklinikum Schleswig-Holstein

Universitätsklinikum Schleswig-Holstein
Klinik für Allgemeine Pädiatrie
Arnold-Heller-Strasse 3, Haus 9
24105 Kiel
Germany

Universitätsklinikum Schleswig-Holstein www.uk-sh.de



Project Leader


Prof. Dr. Paul-Martin Holterhus Prof. Dr. Paul-Martin Holterhus
Phone: 0049-(0)431-597-1626 
Fax: 0049-(0)431-597-1675 
E-Mail to Prof. Dr. Paul-Martin Holterhus Contact  
 

Prof. Dr. Reiner Siebert
Phone: 0049-(0)431-597-1775 
Fax: 0049-(0)431-597-1880 
E-Mail to Prof. Dr. Reiner Siebert Contact  
 



Project Staff


Dr. Ole Ammerpohl
Scientist / DNA-methylation analyses 

Dr. Susanne Bens
Clinician / DNA-methylation analyses 

Mr. Mahesh Appari
PhD student / DNA-methylation, transcription analysis 

Ms. Kerstin Overmoehle
Technician / sample processing 


Institute Presentation


The University Hospital of Schleswig Holstein is a clinic of maximum medical care. Emerged from the joining of the University Hospitals of Lübeck and Kiel, it is one of Europe’s largest hospitals. The campus in Kiel is the largest biomedical University campus in Schleswig-Holstein.

In the Division of Pediatric Endocrinology and Diabetes in Kiel (part of the Department of Pediatrics) more than 3000 cases suffering from Pediatric Endocrine diseases are diagnosed and treated annually. One major focus of our group is the diagnosis, treatment and research on developmental disorders caused by hormonal imbalances including DSD. Therefore, a particular DSD team for inter-disciplinary patient management has been established.

The Department of Human Genetics is working closely together with the Division of Pediatric Endocrinology and Diabetes providing the newest high-tech facilities in genome and epigenome research.

The major contribution of our clinic to the European DSD project will be the determination of the impact of DNA methylation for the development of specific DSD-phenotypes in human. These data will provide valuable novel insights into the regulation of human sex development and individual androgenization. In the future, epigenomic markers of prenatal androgen programming may be of help in clinical studies and individual patient counseling with respect to gender.


Christian-Albrechts-Universität zu Kiel